Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine

Jennifer St. Sauver, Neelam Dhiman, Inna G. Ovsyannikova, Robert M. Jacobson, Robert A. Vierkant, V. Shane Pankratz, Steven J. Jacobsen, Gregory A. Poland

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We have reported associations between human leukocyte antigen (HLA) homozygosity and low measles antibody levels after one dose of the measles, mumps, and rubella (MMR) vaccine. Here, we examined associations between HLA homozygosity and immune responses to MMR after two doses of vaccine. We examined associations between HLA homozygosity and measles antibody levels in a group of 178 children (cohort 1) as well as associations between homozygosity and antibody levels and lymphoproliferative responses to MMR in 346 children (cohort 2). In cohort 1, HLA homozygotes and heterozygotes had similar increases in measles antibody levels after a second dose of measles vaccine. In cohort 2, HLA homozygosity was not associated with measles immune measures after two doses of vaccine. Homozygosity at the DPB locus was associated with increased rubella antibody levels, and homozygosity at the class IA alleles was associated with lower mumps lymphoproliferative response. Homozygosity at increasing numbers of loci was also associated with lower mumps antibody levels and lymphoproliferative response. Therefore, two doses of the MMR vaccine appear to induce sufficient antibody levels and lymphoproliferative responses against measles and rubella, regardless of HLA homozygosity status. However, children who are HLA homozygous may be less protected against mumps compared with children who are heterozygous.

Original languageEnglish (US)
Pages (from-to)788-798
Number of pages11
JournalHuman Immunology
Volume66
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

Measles-Mumps-Rubella Vaccine
Measles
HLA Antigens
Mumps
Rubella
Antibodies
Vaccines
Measles Vaccine
Homozygote
Heterozygote
Alleles

Keywords

  • Cellular immunity
  • HLA
  • Homozygosity
  • Humoral immunity
  • MMR

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

St. Sauver, J., Dhiman, N., Ovsyannikova, I. G., Jacobson, R. M., Vierkant, R. A., Pankratz, V. S., ... Poland, G. A. (2005). Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. Human Immunology, 66(7), 788-798. https://doi.org/10.1016/j.humimm.2005.03.008

Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. / St. Sauver, Jennifer; Dhiman, Neelam; Ovsyannikova, Inna G.; Jacobson, Robert M.; Vierkant, Robert A.; Pankratz, V. Shane; Jacobsen, Steven J.; Poland, Gregory A.

In: Human Immunology, Vol. 66, No. 7, 07.2005, p. 788-798.

Research output: Contribution to journalArticle

St. Sauver, J, Dhiman, N, Ovsyannikova, IG, Jacobson, RM, Vierkant, RA, Pankratz, VS, Jacobsen, SJ & Poland, GA 2005, 'Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine', Human Immunology, vol. 66, no. 7, pp. 788-798. https://doi.org/10.1016/j.humimm.2005.03.008
St. Sauver, Jennifer ; Dhiman, Neelam ; Ovsyannikova, Inna G. ; Jacobson, Robert M. ; Vierkant, Robert A. ; Pankratz, V. Shane ; Jacobsen, Steven J. ; Poland, Gregory A. / Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. In: Human Immunology. 2005 ; Vol. 66, No. 7. pp. 788-798.
@article{9d1a9640a16042de9f7e153706fb3dc7,
title = "Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine",
abstract = "We have reported associations between human leukocyte antigen (HLA) homozygosity and low measles antibody levels after one dose of the measles, mumps, and rubella (MMR) vaccine. Here, we examined associations between HLA homozygosity and immune responses to MMR after two doses of vaccine. We examined associations between HLA homozygosity and measles antibody levels in a group of 178 children (cohort 1) as well as associations between homozygosity and antibody levels and lymphoproliferative responses to MMR in 346 children (cohort 2). In cohort 1, HLA homozygotes and heterozygotes had similar increases in measles antibody levels after a second dose of measles vaccine. In cohort 2, HLA homozygosity was not associated with measles immune measures after two doses of vaccine. Homozygosity at the DPB locus was associated with increased rubella antibody levels, and homozygosity at the class IA alleles was associated with lower mumps lymphoproliferative response. Homozygosity at increasing numbers of loci was also associated with lower mumps antibody levels and lymphoproliferative response. Therefore, two doses of the MMR vaccine appear to induce sufficient antibody levels and lymphoproliferative responses against measles and rubella, regardless of HLA homozygosity status. However, children who are HLA homozygous may be less protected against mumps compared with children who are heterozygous.",
keywords = "Cellular immunity, HLA, Homozygosity, Humoral immunity, MMR",
author = "{St. Sauver}, Jennifer and Neelam Dhiman and Ovsyannikova, {Inna G.} and Jacobson, {Robert M.} and Vierkant, {Robert A.} and Pankratz, {V. Shane} and Jacobsen, {Steven J.} and Poland, {Gregory A.}",
year = "2005",
month = "7",
doi = "10.1016/j.humimm.2005.03.008",
language = "English (US)",
volume = "66",
pages = "788--798",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine

AU - St. Sauver, Jennifer

AU - Dhiman, Neelam

AU - Ovsyannikova, Inna G.

AU - Jacobson, Robert M.

AU - Vierkant, Robert A.

AU - Pankratz, V. Shane

AU - Jacobsen, Steven J.

AU - Poland, Gregory A.

PY - 2005/7

Y1 - 2005/7

N2 - We have reported associations between human leukocyte antigen (HLA) homozygosity and low measles antibody levels after one dose of the measles, mumps, and rubella (MMR) vaccine. Here, we examined associations between HLA homozygosity and immune responses to MMR after two doses of vaccine. We examined associations between HLA homozygosity and measles antibody levels in a group of 178 children (cohort 1) as well as associations between homozygosity and antibody levels and lymphoproliferative responses to MMR in 346 children (cohort 2). In cohort 1, HLA homozygotes and heterozygotes had similar increases in measles antibody levels after a second dose of measles vaccine. In cohort 2, HLA homozygosity was not associated with measles immune measures after two doses of vaccine. Homozygosity at the DPB locus was associated with increased rubella antibody levels, and homozygosity at the class IA alleles was associated with lower mumps lymphoproliferative response. Homozygosity at increasing numbers of loci was also associated with lower mumps antibody levels and lymphoproliferative response. Therefore, two doses of the MMR vaccine appear to induce sufficient antibody levels and lymphoproliferative responses against measles and rubella, regardless of HLA homozygosity status. However, children who are HLA homozygous may be less protected against mumps compared with children who are heterozygous.

AB - We have reported associations between human leukocyte antigen (HLA) homozygosity and low measles antibody levels after one dose of the measles, mumps, and rubella (MMR) vaccine. Here, we examined associations between HLA homozygosity and immune responses to MMR after two doses of vaccine. We examined associations between HLA homozygosity and measles antibody levels in a group of 178 children (cohort 1) as well as associations between homozygosity and antibody levels and lymphoproliferative responses to MMR in 346 children (cohort 2). In cohort 1, HLA homozygotes and heterozygotes had similar increases in measles antibody levels after a second dose of measles vaccine. In cohort 2, HLA homozygosity was not associated with measles immune measures after two doses of vaccine. Homozygosity at the DPB locus was associated with increased rubella antibody levels, and homozygosity at the class IA alleles was associated with lower mumps lymphoproliferative response. Homozygosity at increasing numbers of loci was also associated with lower mumps antibody levels and lymphoproliferative response. Therefore, two doses of the MMR vaccine appear to induce sufficient antibody levels and lymphoproliferative responses against measles and rubella, regardless of HLA homozygosity status. However, children who are HLA homozygous may be less protected against mumps compared with children who are heterozygous.

KW - Cellular immunity

KW - HLA

KW - Homozygosity

KW - Humoral immunity

KW - MMR

UR - http://www.scopus.com/inward/record.url?scp=23844558901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844558901&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2005.03.008

DO - 10.1016/j.humimm.2005.03.008

M3 - Article

C2 - 16112026

AN - SCOPUS:23844558901

VL - 66

SP - 788

EP - 798

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 7

ER -